GlassScriptPhysician profile
Soheil Jamshidi
NPI 1679189443
$1,452.66
in general payments reported to CMS, 2019-2025
13 companies · $56.42 in 2025
The $56.42 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $134 · 2021: $425 · 2022: $553 · 2023: $252 · 2024: $32.19 · 2025: $56.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $289.62 | 2021-2025 | Venaseal, Closurefast |
| Angiodynamics, INC. | $248.61 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $174.64 | 2021-2022 | |
| Philips North America LLC | $164.95 | 2022 | |
| Boston Scientific Corporation | $162.53 | 2021-2025 | Varithena Administration Pack |
| Shockwave Medical, INC | $125.39 | 2021 | |
| Baxter Healthcare | $115.76 | 2022 | |
| Pfizer INC. | $36.64 | 2021-2022 | |
| Endologix LLC | $34.59 | 2021 | |
| Bard Peripheral Vascular, INC. | $34.28 | 2021-2022 | |
| Getinge USA Sales, LLC | $32.09 | 2021-2022 | |
| Cardiva Medical, INC. | $18.54 | 2023 | Cardiva Vascade 6/7f Vcs |
| Cordis US Corp. | $15.02 | 2023 | Brite Tip Radianz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soheil Jamshidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.